Gerd Blobel Laboratory

Ongoing Research

Pharmacologic inhibition of BET protein function may represent a new treatment option for childhood hematologic cancers and related blood disorders.

Studies to help understand the factors that participate in mitotic memory may lead to identification of new therapies to treat hematologic cancer and related blood disorders.

Researchers are pursing questions of how chromatin is organized in the nucleus, specifically, how enhancer-promoter contacts are formed.